Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is the cornerstone of the management of patients with MASLD, cardiovascular disease risk must be properly assessed and managed because cardiovascular disease is the leading cause of mortality. No pharmacological agent has been approved for the treatment of MASLD, but novel anti-hyperglycemic drugs appear to have benefit. Medications used for the treatment of diabetes and other metabolic conditions may need to be adjusted as liver disease progresses to cirrhosis, especially decompensated cirrhosis. Based on non-invasive tests, the concepts of compensated advanced chronic liver disease and clinically significant portal hypertension provide a practical approach to stratifying patients according to the risk of liver-related complications and can help manage such patients. Finally, prevention and management of sarcopenia should be considered in the management of patients with MASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The growing yearly prevalence of Metabolic Dysfunction–non-alcoholic fatty liver disease (MASLD) has emerged as a worldwide public health concern, driven by improved living conditions, evolving lifestyle habits, and the widespread occurrence of obesity, diabetes, and metabolic syndrome.1”
From The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is because the clinical definition of MASLD, as previously noted, includes not only the presence of steatosis but also a cardiometabolic context [31,32,33], which cannot be fully reproduced in a monoculture of hepatocyte-like cells.”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Cited by
Items 601–700 of 784
Wu, Y., Gao, H., Liu, C., & Gao, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011924
Differentiating MASL and MASH: Clinical Insights from Comparative Case Reports in MASLD
Son, C. (2025) · The Journal of Internal Korean Medicine · doi:10.22246/jikm.2025.46.4.954
Paolucci, G., Basolo, A., Fierabracci, P., & Santini, F. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01713-x
Smirnova, O. V., Sinyakov, A. A., & Kasparov, E. V. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.110833
Diabetes mellitus and hepatosteatosis: a narrative review
Kösekli, M. A. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101446
Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis
Dai, J., Selvaraj, E. A., Culver, E. L., Bailey, A. A., Brady, M., Pavlides, M., & Leal, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335642
Xiaoheng, L., & chen, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-8134919/v1
Fuad, N. A., Alifianti, A., Harum, N. A., & Cheng, W. (2025) · Jurnal Gastrohepatologi Anak Indonesia/Archives of Pediatric Gastroenterology, Hepatology, and Nutrition · doi:10.58427/apghn.4.4.2025.174-188
Kresevic, S., Giuffrè, M., Moretto, C., Zucchini, L., Miladinović, A., Bongiovanni, M., Bortolotto, A., Discipio, M., Stella, A. B., Accardo, A., et al. (2025) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc58623.2025.11253032
Gualdieri, F., Rocha, G. E., Iacono, R. F., Marzi, M. C. D., & Guerra, L. N. (2025) · Plant Foods for Human Nutrition · doi:10.1007/s11130-025-01452-2 · Cited by 1
Zhaivoronok, M., Dynnyk, O., Deresh, N., Abenavoli, L., & Kobyliak, N. M. (2025) · WFUMB Ultrasound Open · doi:10.1016/j.wfumbo.2025.100083
Zanni, E., Coluccia, S., Boni, S., Colzani, M., Sueri, R., Lugari, S., Felicani, C., Nascimbeni, F., & Greco, C. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.89
Arnaud, I., Rodriguez-Contreras, F., Muñoz, V. Y. A., Pulido, M., Rios‐Olais, F. A., Ontiveros-Austria, J. L., & Demichelis‐Gómez, R. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2604567
Nambiar, A., Karambelkar, K., Athreya, A. P., Allen, A. M., Lazaridis, K. N., Donovan, S. M., & Maslov, S. (2025) · medRxiv · doi:10.64898/2025.12.18.25342567
Zhang, M., Wang, Y., Liu, M., Shi, Q., Wu, X., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1692394
Noskova, E. V., & Симонова, Ж. Г. (2025) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2025-6-4-124-131
Pharmacologic glycemic management of type 2 diabetes
Mourelatou, N. G., & Rebelos, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00284-3
Armas-Téllez, S. N., Castillo-Flores, P. S. N., Uribe, M., & Barbero-Becerra, V. J. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr42608
Dietary Ethanolamine Increases Hepatic Lipid Accumulation in Mice Fed a High-Fat Diet
Holdaway, C. M., Vo, A., Leonard, K., Nelson, R., Thiesen, A., Fan, Y., Marcolla, C. S., Clugston, R. D., Willing, B. P., & Jacobs, R. L. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.101348
Editorial: Micronutrients and metabolic diseases - volume II
Li, J., Yang, A., Luo, Y., & An, P. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1758663
Quantitative Multifrequency Ultrasound Imaging Using Narrowband Pulsing for Tissue Characterization
Hanson, J. P., Wu, C., & Hoyt, K. (2026) · Investigative Radiology · doi:10.1097/rli.0000000000001269 · Cited by 1
Srinivas, A. N., Suresh, D., Anirvan, P., Moorthy, M., Ramaswamy, G., Nataraj, S. M., Santhekadur, P. K., Suvarna, D., Singh, S. P., & Kumar, D. P. (2026) · Molecular Medicine · doi:10.1186/s10020-025-01417-w
Li, Y., Guo, R., Qian, Y., Hawro, I., Córdoba‐Chacón, J., Jiang, Y., & Song, Z. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00379.2025
Poor Access to Anti-Obesity Medications in Metabolic Dysfunction-Associated Steatotic Liver Disease
Hurr, S., Giang, J., & Barritt, A. S. (2026) · North Carolina Medical Journal · doi:10.18043/001c.154980
Berlana, Á., Rey, E., Fresno-Ventura, E., Gómez‐Gutierrez, P., Vega, M., García‐Monzón, C., & González‐Rodríguez, Á. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119052
Sexual Dimorphism in Hepatocellular Carcinoma Progression via ERα-Gα12 Signaling
Tak, J., & Kim, S. G. (2026) · Springer eBooks · doi:10.1007/978-981-95-2070-1_3
Vijukumar, A., Singh, G., Aggarwal, M., Sharma, A., & Sandhu, N. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_17
Aydagnuhm, G. B., Tefera, A. S., Tesfaw, G., & Melaku, E. E. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04656-1 · Cited by 1
Kouti, T., Christodoulou, P., Christodoulides, S., Protopapa, F., Michaeloudes, C., & Farazi, P. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1767917 · Cited by 1
Andrade, L. J. D. O., de Oliveira, G. C. M., Paraná, R., Bittencourt, A. M. V., Salles, O. J. D. M., & de Oliveira, L. M. (2026) · Research Square · doi:10.21203/rs.3.rs-8818597/v1
Durantaş, H., Boz, O., Unver, C. K., Fedai, N. K., Çakal, B., Hepşen, S., & Çakal, E. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02196-z · Cited by 2
La gran refinería del cuerpo: un viaje al interior del hígado
Juarez, B., Hernández, L., Ruiz, L., & Méndez, I. G. (2026) · Revista Digital Universitaria · doi:10.22201/ceide.16076079e.2026.27.1.6
Șufaru, I.-G., Mârţu, I., Păsărin, L., Mârțu, M.-A., Tatarciuc, D., Luca, I., Phd. Student, ”. T. P. U. M. P. ". I., Mârţu, S., & Solomon, S. M. (2025) · Romanian Journal of Oral Rehabilitation · doi:10.62610/rjor.2025.4.17.11
Zhong, X., Nickel, D. M., Dale, B. M., Morin, C. E., Abramson, Z. R., Pang, Y., Han, F., Deshpande, V. S., Kannengießer, S., & Tipirneni‐Sajja, A. (2026) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-026-01333-y · Cited by 2
Tjandra, N., Fonzo, D. M. D., Wen, T., Lau, K., Lin, Y., Kwan, P. W., Yoshida, E. M., & Chahal, D. (2026) · Canadian Liver Journal · doi:10.3138/canlivj-2025-0046
Hussain, R., Raut, C., Prabhu, P., Irshaid, A., Hegde, Y. D., Chen, Y., Pant, A., Oliveri, A., Wei, X., Yin, L., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101013
Aydin, A., Aydin, Y., & Borz-Baba, C. (2026) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003161
Qiu, D., Suo, L., Wei, T., Lu, Z., Weng, Q., Xiao, J., Wang, X., Xu, Q., & Wu, J. (2026) · Biomedicines · doi:10.3390/biomedicines14030630
Hofer, H., Wernly, S., Semmler, G., Flamm, M., Völkerer, A., Singhartinger, F. X., Jung, C., Erkens, R., Ausserwinkler, M., Aigner, E., et al. (2026) · Open Heart · doi:10.1136/openhrt-2026-003982
Alakuş, Ö. F., Solmaz, İ., KILIC, J., & Çiçek, S. (2026) · Diagnostics · doi:10.3390/diagnostics16060872
Yuanze, G., Wang, F., Ganesan, K., & Chen, J. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3176-0
Incretin polyagonists as an alternative to bariatric surgery to manage obesity
Manoj, R. J., Fernandez, C. J., Nair, S., & Pappachan, J. M. (2026) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v17.i1.118132
Blathra, E., & Liberopoulos, E. N. (2025) · Journal of Atherosclerosis Prevention and Treatment · doi:10.4103/aptj.aptj_16_25
Zhang, Z., Ma, Z., Zhang, R., Ye, M., Shi, Z., Yu, M., & Ou, L. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00690-7 · Cited by 1
Alam, U., Rath, S., Ansab, M., Kashif, A., Sethi, F. A., Siddiqui, H. T., Afridi, Z., Burhan, M., Ali, M. A., Moiz, A., et al. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i3.115411
Salah, T., Stahl, M., & Bewersdorf, J. P. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2640454
Emad, R., AlSinani, S., El‐Kassas, M., Eslam, M., Alqahtani, S. A., YILMAZ, Y., Emad, B., Alswat, K., Al-Dury, S., Sanai, F. M., et al. (2026) · Liver International · doi:10.1111/liv.70605
Choi, Y., Kim, E., Park, S., Kang, Y.-H., & Jeon, S. (2026) · Journal of Medicinal Food · doi:10.1177/1096620x261438294
Papadakis, Z. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.03.103 · Cited by 1
Semnani, K., Semnani, F., Aarabi, S. S., Esmaeili, S., Taheri, E. M. F., Mahdavi‐Gorabi, A., Rajabnia, M., Djalalinia, S., Goodarzi, S., Kasaeian, A., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111933
Wang, Z., Yu, Z., An, W., Wei, H., Luo, J., Li, M., He, L., Ma, J., Xiao, F., Sun, L., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-04252-9
Zhou, Y., Xu, D., Bu, M., Li, K., Gao, L., Pan, F., Peng, W., Chen, H., & Tian, W. (2026) · Foods · doi:10.3390/foods15081384 · Cited by 1
Guo, C., Rong, Y., Wang, L., Bai, Y., Guo, Y., Guo, F., Zhang, L., Bai, P., Zhang, M., & Li, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-04417-6
Zhang, Z.-R., She, L., Cao, Y., & Chen, Y.-W. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i4.116074
McLaughlin, A., Manning, M. E., Lai, M., & Fricker, Z. P. (2026) · Journal of Addictive Diseases · doi:10.1080/10550887.2026.2639428
Weerarathna, T. P., Wasana, K. G. P., Kodikara, I., & Weerarathna, S. R. (2026) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0257
Rivera, R., Castaneda, R., Sobel, T., & Andrade, M. D. H. (2026) · Springer eBooks · doi:10.1007/978-3-032-18203-6_8 · Cited by 3
Elsaid, M. I., Kweon, Y., Li, N., Fernández, S., Paskett, E. D., Mumtaz, K., & Rustgi, V. K. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100992
Wu, C., Lin, M., Wang, C.-Y., Chang, C.-Y., Lee, F., Cheng, M., Lin, Y., Chen, T., Hsiao, Y.-T., Wang, B.-W., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104186
Shahmansouri, M., Cheraghian, B., Bavarsad, A. H., & Rahimi, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-9415232/v1
Song, W., & Ke, Z. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1760364
Álvarez-Guaita, A., Cabrera-Serra, J., Perez-Gonzalez, B., Salcedo, M. T., Fuertes‐Rioja, L., Ramos‐Perez, L., Hernández, C., Simó, R., & Selva, D. M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08305-9 · Cited by 1
Tang, W., Ding, W., Deng, L., Wang, D., Wang, H., Li, Y., & Ma, R. (2026) · Nutrients · doi:10.3390/nu18101586 · Cited by 1
Rehan, N., Benedict, J., & Qayyum, R. (2026) · JGH Open · doi:10.1002/jgh3.70417
de la Blanca, N. S., García-Díez, E., Garcimartín, A., Knott-Torcal, C., Serrano-Somavilla, A., Sebastián‐Valles, F., Sampedro-Nuñez, M. A., Ruiz-Roso, M. B., Santander, C., Martínez‐Hernández, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9265488/v1
Lowry, S. B., & Karnsakul, W. W. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102849
Akkuş, C., Sönmez, G., Şahin, A., Yazarkan, Y., Gökgöz, M., Çağlar, F., & Kayhan, S. (2026) · Biomedicines · doi:10.3390/biomedicines14051154
Sleep factors and metabolic dysfunction-associated steatotic liver disease in NHANES adults
Cai, M.-L., Qiu, H.-B., Liao, D.-P., & Chen, H. (2026) · Exploration of Digestive Diseases · doi:10.37349/edd.2026.1005123
Lian, J., Patil, M., Lareu, R. R., & Falasca, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114872 · Cited by 1
ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (−)-Epicatechin in MASLD
Hefer, M., Filipović, N., Šarić, S., Malatesti, N., Petrović, A., Kovač-Andrić, E., & Smolić, M. (2026) · ACS Omega · doi:10.1021/acsomega.5c09978
Palmer, M., Hashiguchi, T., Arman, A. C., Shirakata, Y., E.Buss, N., & Lalezari, J. P. (2026) · ASEAN Journal of Psychiatry · doi:10.54615/2231-7805.26.15.281
Tian, R., Wu, Y.-X., Guo, J.-Y., Chen, X., Tang, J.-F., & Zhou, C.-F. (2026) · World Journal of Hepatology · doi:10.4254/wjh.117382
Peng, A., Wang, R., Yu, Z., Li, Y., Ma, Z., Hu, Y., Qiu, Y., & Qi, R. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121964
Naqash, M., Tariq, A., Shayan, S., Sargani, S. M., Raza, M. A., Khan, N., Balouch, A., Usama, R. M., & Ahmed, K. A. H. M. (2026) · International Journal of Hepatology · doi:10.1155/ijh/7391450
Gerdanovics, C.-A., Suciu, S., Orășan, O.-H., Para, I., Turi, V., Tǎut, A. V. S., Milaciu, M. V., Perné, M.-G., Alexescu, T., Ciumărnean, L., et al. (2026) · Antioxidants · doi:10.3390/antiox15060684
Nie, J., Zhou, J., Yuanjia, H., Zhang, C., Yu, P., & Lei, X. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s590383
МЕНЕДЖМЕНТ ХРОНІЧНОЇ ХВОРОБИ ПЕЧІНКИ НА ПЕРВИННОМУ РІВНІ НАДАННЯ МЕДИЧНОЇ ДОПОМОГИ
ЛАЗАРЧУК, Т., & Levchyk, O. I. (2026) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2026.v.i2.16389
Masuda, H., Namisaki, T., Kaji, K., Nishimura, N., Takaya, H., Inoue, T., Shibamoto, A., Iwai, S., Takami, M., Tsuji, Y., et al. (2026) · Hepatology Research · doi:10.1111/hepr.70217
Chen, F., You, R., Liu, Y., Yin, Y., Liu, A., Deng, L., Xie, B., Fan, J., & Wang, W. (2026) · medRxiv · doi:10.64898/2026.06.05.26354982
Zarei, M., & Hajiani, Y. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02196-y
Salman, O., Sanayeh, E. B., Itani, H., Lahoud, C., Wei, C., Mustafa, A., Raghunathan, A., Moussa, E., & Amor, M. M. I. (2026) · Medicina · doi:10.3390/medicina62061147
Probiotic, synbiotic effects on the gut–liver axis: omics-enabled mechanisms and therapeutic windows
Oriquat, G., El‐Sehrawy, A. A. M. A., Abdulsahib, W. K., Mustafa, W. W., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., Sinha, A., & Yazdi, F. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2684877
Beig, J., Ta, J., Jones, S., Scott, E., Sofi, K., Osler, F., Jansen, M., & Chhabra, P. (2026) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.70059 · Cited by 1
Zhang, J., 沈兴华, Liu, J., Xu, J., Huang, L., Ni, H., Tang, P., Feng, Y., Wu, M., & Shi, C. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s598998
Bandara, D., Joshi, K., Singh, C. M., Sohal, A., Al-Qaisi, M. T., & Najafian, N. (2026) · World Journal of Virology · doi:10.5501/wjv.v15.i2.120027
Cho, H. J., Kang, S. H., Chon, H. Y., Bae, S., Kim, E., Na, S. K., Kim, S. J., Kim, D., Ahn, H. R., Kim, H., et al. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e258
Gonçalves, J. C., Souto, M., Ferreira, A. I., Magalhães, J., & Cotter, J. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.113035
Kim, H., Yoo, J., Chang, Y. W., Jang, J. Y., Ryu, T., Jeong, S. W., Kim, S. G., Kim, Y. S., & Park, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1832416
Gorke, S., Sharma, S., Malik, A., & Abdullah, I. A. W. A. S. T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1015589
Beyond the Liver: Insights into the Liver–Brain Axis in MASLD and MASH
Patel, S. R., Smith, J., & Siddiqui, M. S. (2026) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2026.103597
Barbhuiya, P. A., Talukdar, S., Chetia, S. J., Radice, M., & Pathak, M. P. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100520
Hsu, C., & Tain, Y. (2026) · Antioxidants · doi:10.3390/antiox15060769 · Cited by 1
Zhong, C., Boame, N., Gbadamosi, S. O., JARA, M., Luthra, R., Salamun, A., Hong, Y., Aly, A., Bril, F., & Rinella, M. E. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2692644
Tatoli, R., Donghia, R., Casimo, G., Pesole, P. L., & Bonfiglio, C. (2026) · Antioxidants · doi:10.3390/antiox15070802
Ahmed, A., & Pathak, M. P. (2026) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2026.2693505
Song, Z., Sun, H., Cai, W., Qi, Y., & Liu, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1862426
Obesity from the perspective of the liver
Csala, M., & Mandl, J. (2026) · Pathology & Oncology Research · doi:10.3389/pore.2026.1612376
Wu, J., Zheng, W., Qi, Q., He, C., Zhai, C., & Fan, H. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm51234 · Cited by 1
Huang, H., Lu, Y., Luo, T., Wu, H., Li, J., Tang, T., Xv, X., Wu, J., & Chen, M. Y. (2026) · JGH Open · doi:10.1002/jgh3.70435
Metadata
- Authors
- Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R.
- Affiliations
- University of Malaya (MY)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Wah-Kheong
- Venue
- Journal of Obesity & Metabolic Syndrome
- Published
- 2023-09-13
- Volume
- 32
- Issue
- 3
- Pages
- 197-213
- ISSN
- 2508-6235 (ISSN-L)
- 2508-7576
- PMC
- PMC10583766
- OpenAlex
- W4386704735
- Cited by
- 776
- References
- 122
- Citations by year
- 2026: 245 · 2025: 342 · 2024: 183 · 2023: 5
- FWCI
- 30.29
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Journal of Obesity & Metabolic Syndrome (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, metabolic syndrome, obesity, chronic liver disease, non-invasive liver assessment, referral pathways, lifestyle intervention, cardiovascular risk, anti-hyperglycemic drugs, liver cirrhosis, decompensated cirrhosis, compensated advanced chronic liver disease, clinically significant portal hypertension, sarcopenia, liver complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.